Similar articles for PMID: 26522089

Year	Number of Results
1948	1
1949	1
1951	1
1955	1
1956	2
1959	1
1962	1
1972	1
2001	1
2002	2
2003	2
2004	1
2005	1
2006	2
2007	5
2008	5
2009	6
2010	9
2011	14
2012	14
2013	15
2014	19
2015	22
2016	15
2017	15
2018	17
2019	15
2020	12
2021	10
2022	8
2023	4
2024	0

1

Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.

Soares de Melo C, Feng TS, van der Westhuyzen R, Gessner RK, Street LJ, Morgans GL, Warner DF, Moosa A, Naran K, Lawrence N, Boshoff HI, Barry CE 3rd, Harris CJ, Gordon R, Chibale K. Soares de Melo C, et al. Bioorg Med Chem. 2015 Nov 15;23(22):7240-50. doi: 10.1016/j.bmc.2015.10.021. Epub 2015 Oct 22. Bioorg Med Chem. 2015. PMID: 26522089

2

Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.

Pathak V, Maurya HK, Sharma S, Srivastava KK, Gupta A. Pathak V, et al. Bioorg Med Chem Lett. 2014 Jul 1;24(13):2892-6. doi: 10.1016/j.bmcl.2014.04.094. Epub 2014 May 4. Bioorg Med Chem Lett. 2014. PMID: 24835631

3

Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.

Trivedi A, Vaghasiya S, Dholariya B, Dodiya D, Shah V. Trivedi A, et al. J Enzyme Inhib Med Chem. 2010 Dec;25(6):893-9. doi: 10.3109/14756360903540276. J Enzyme Inhib Med Chem. 2010. PMID: 21054238

4

Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.

Rashmi P, Nargund LV, Hazra K, Chandra JN. Rashmi P, et al. Arch Pharm (Weinheim). 2011 Jul;344(7):459-65. doi: 10.1002/ardp.201000394. Epub 2011 May 20. Arch Pharm (Weinheim). 2011. PMID: 21598298

5

Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group.

Yadlapalli RK, Chourasia OP, Vemuri K, Sritharan M, Perali RS. Yadlapalli RK, et al. Bioorg Med Chem Lett. 2012 Apr 15;22(8):2708-11. doi: 10.1016/j.bmcl.2012.02.101. Epub 2012 Mar 7. Bioorg Med Chem Lett. 2012. PMID: 22437116

6

Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.

Chhabria MT, Jani MH. Chhabria MT, et al. Eur J Med Chem. 2009 Oct;44(10):3837-44. doi: 10.1016/j.ejmech.2009.04.002. Epub 2009 Apr 8. Eur J Med Chem. 2009. PMID: 19423196

7

Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis.

Castagnolo D, De Logu A, Radi M, Bechi B, Manetti F, Magnani M, Supino S, Meleddu R, Chisu L, Botta M. Castagnolo D, et al. Bioorg Med Chem. 2008 Sep 15;16(18):8587-91. doi: 10.1016/j.bmc.2008.08.016. Epub 2008 Aug 7. Bioorg Med Chem. 2008. PMID: 18752962 Free article.

8

4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents.

Siddiqui AB, Trivedi AR, Kataria VB, Shah VH. Siddiqui AB, et al. Bioorg Med Chem Lett. 2014 Mar 15;24(6):1493-5. doi: 10.1016/j.bmcl.2014.02.012. Epub 2014 Feb 14. Bioorg Med Chem Lett. 2014. PMID: 24582983

9

Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.

Ali MA, Yar MS. Ali MA, et al. Acta Pol Pharm. 2007 Mar-Apr;64(2):139-46. Acta Pol Pharm. 2007. PMID: 17665863 Free article.

10

Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.

Abdel-Rahman HM, El-Koussi NA, Hassan HY. Abdel-Rahman HM, et al. Arch Pharm (Weinheim). 2009 Feb;342(2):94-9. doi: 10.1002/ardp.200800113. Arch Pharm (Weinheim). 2009. PMID: 19173243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

198 results

Results by year